Daniel R. Farnell
- Co-authors
- Clinton J. GrubbsDonald L. HillJames E. HeathKaren C. McDonoughCharles LindamoodAnn RadovskyJoseph PrejeanAndres J. Klein–Szanto
- Topics
- Carcinogens and Genotoxicity Assessment (6 papers)Drug Transport and Resistance Mechanisms (2 papers)Polyamine Metabolism and Applications (2 papers)
- Journals
- JNCI Journal of the National Cancer InstituteFood and Chemical ToxicologyToxicology and Applied Pharmacology
- Partner nations
- United States
In The Last Decade
Daniel R. Farnell
13 papers receiving 372 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 138
- Oncology 87
- Cancer Research 86
- Health, Toxicology and Mutagenesis 79
- Genetics 79
Countries citing papers authored by Daniel R. Farnell
This map shows the geographic impact of Daniel R. Farnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Farnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Farnell more than expected).
Fields of papers citing papers by Daniel R. Farnell
This network shows the impact of papers produced by Daniel R. Farnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Farnell. The network helps show where Daniel R. Farnell may publish in the future.
Co-authorship network of co-authors of Daniel R. Farnell
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Farnell. A scholar is included among the top collaborators of Daniel R. Farnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Farnell. Daniel R. Farnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. | 102 |
| 2 | 5 | |
| 3 | 39 | |
| 4 | 29 | |
| 5 | 2 | |
| 6 | 82 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 14 | |
| 10 | 88 | |
| 11 | 10 | |
| 12 | 10 | |
| 13 | 2 | |
| 14 | Cortisone treatment in magnesium deficiency of rats. | 2 |
About Daniel R. Farnell
Daniel R. Farnell is a scholar working on Cancer Research, Biochemistry and Physiology, having authored 14 papers that have together received 387 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (6 papers), Drug Transport and Resistance Mechanisms (2 papers) and Polyamine Metabolism and Applications (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (79 citations), Cancer Research (86 citations) and Pharmacology (57 citations). Daniel R. Farnell has collaborated with scholars based in United States. Frequent co-authors include Clinton J. Grubbs, Donald L. Hill, James E. Heath, Karen C. McDonough, Charles Lindamood, Ann Radovsky, Joseph Prejean, Andres J. Klein–Szanto, William J. Thompson and Gary A. Piazza. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Food and Chemical Toxicology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.